Internal Medicine, Hematology & Oncology · Ponce, PR
NPI
1952405425
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1217 Ave Hostos, Suite 101
Ponce, PR, 00717
Phone (787) 259-7807
Medicare paid, 2024
$222K
7,761 services
Medicare patients, 2024
40
Average age 77
Drug cost, 2024
$10.2M
2,842 prescriptions
Company payments, 2025
$161
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hector A Velez Cortes was code 99214 (office e&m - established), 68 times for 32 patients. In total Hector A Velez Cortes billed 7,761 services in 32 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 68 | 32 | $62.08 | $4,221 |
By year: 2022 $348K for 18,550 services; 2023 $279K for 18,732 services; 2024 $222K for 7,761 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hector A Velez Cortes prescribed most often to Medicare patients was Anastrozole, with 324 prescriptions and refills. In total Hector A Velez Cortes wrote 2,842 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 324 | 435 | 60 | $5,599 |
| Hydroxyurea Generic | 239 | 257 | 40 | $6,017 |
| Tamoxifen Citrate Generic | 192 | 298 | 38 | $6,420 |
| Dexamethasone Generic | 149 | 149 | 39 | $3,425 |
| Prednisone Generic | 141 | 150 | 53 | $1,145 |
| Imatinib Mesylate Generic | 119 | 119 | 15 | $181K |
| Revlimid Lenalidomide | 117 | 117 | 17 | $2.2M |
| Letrozole Generic | 104 | 124 | 20 | $1,532 |
| Abiraterone Acetate Generic | 88 | 88 | 17 | $37K |
| Ondansetron Hcl Generic | 87 | 87 | 59 | $1,227 |
| Ibrance Palbociclib | 69 | 69 | Under 11 | $1.1M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 67 | 67 | 22 | $1,070 |
| Synthroid Levothyroxine Sodium | 59 | 61 | 16 | $3,024 |
| Tasigna Nilotinib Hcl | 45 | 45 | Under 11 | $747K |
| Sprycel Dasatinib | 45 | 45 | Under 11 | $568K |
Brand drugs: - claims; generic drugs: 2,048 claims; opioid claims: 123.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hector A Velez Cortes $161 ($161 in general payments such as food, travel and fees) from 7 companies. The largest payer was Merck Sharp & Dohme LLC with $123.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.